Kim, D.-H.; Lee, J.; Lee, D.-Y.; Lee, S.-H.; Jeong, J.-H.; Kim, J.-Y.; Kim, J.; Choi, Y.-K.; Lee, J.-B.; Park, S.-Y.;
et al. Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection. Vaccines 2024, 12, 921.
https://doi.org/10.3390/vaccines12080921
AMA Style
Kim D-H, Lee J, Lee D-Y, Lee S-H, Jeong J-H, Kim J-Y, Kim J, Choi Y-K, Lee J-B, Park S-Y,
et al. Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection. Vaccines. 2024; 12(8):921.
https://doi.org/10.3390/vaccines12080921
Chicago/Turabian Style
Kim, Deok-Hwan, Jiho Lee, Da-Ye Lee, Seung-Hun Lee, Jei-Hyun Jeong, Ji-Yun Kim, Jiwon Kim, Yang-Kyu Choi, Joong-Bok Lee, Seung-Young Park,
and et al. 2024. "Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection" Vaccines 12, no. 8: 921.
https://doi.org/10.3390/vaccines12080921
APA Style
Kim, D.-H., Lee, J., Lee, D.-Y., Lee, S.-H., Jeong, J.-H., Kim, J.-Y., Kim, J., Choi, Y.-K., Lee, J.-B., Park, S.-Y., Choi, I.-S., Lee, S.-W., Youk, S., & Song, C.-S.
(2024). Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection. Vaccines, 12(8), 921.
https://doi.org/10.3390/vaccines12080921
